• Consensus Rating: Buy
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 83.55
▼ -0.95 (-1.12%)

This chart shows the closing price for IXI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New IXICO Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IXI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IXI

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for IXICO in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 83.55.

This chart shows the closing price for IXI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in IXICO.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/24/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/22/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/20/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/20/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/19/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/17/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/17/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/6/2021Shore CapitalReiterated RatingBuy
5/25/2021Shore CapitalReiterated RatingHouse Stock
5/19/2021Shore CapitalReiterated RatingBuy
4/26/2021Shore CapitalReiterated RatingBuy
3/10/2021Shore CapitalReiterated RatingBuy
10/20/2020Shore CapitalReiterated RatingBuy
8/9/2019Shore CapitalReiterated RatingBuy
(Data available from 10/18/2016 forward)

News Sentiment Rating

0.59 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/20/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/20/2021
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/19/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/18/2021
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/18/2021

Current Sentiment

  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
IXICO logo
IXICO plc provides data analytics services to the biopharmaceutical industry in the United States, the United Kingdom, Europe, and internationally. It provides collection, analysis, management, and reporting services on data generated in the course of a clinical study. The company's technologies include Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, QC, and reading/analysis to reporting and data transfer. The company offers end-to-end imaging services in the fields of Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, And Progressive Supranuclear Palsy, Spinocerebellar Ataxia, and Friedreich's Ataxia diseases, as well as other movement disorders and dementias; and engages in the data collection and analysis of neurological diseases. Its services are used to select patients for clinical trials, assess the safety and efficacy of new drugs in development, and in post marketing surveillance. The company was incorporated in 1995 and is based in London, the United Kingdom.
Read More

Today's Range

Now: GBX 83.55
Low: 83
High: 91

50 Day Range

MA: GBX 77.87
Low: 73.86
High: 84.50

52 Week Range

Now: GBX 83.55
Low: 55
High: 127

Volume

195,507 shs

Average Volume

117,776 shs

Market Capitalization

£40.23 million

P/E Ratio

30.94

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of IXICO?

The following Wall Street sell-side analysts have issued reports on IXICO in the last year: Shore Capital.
View the latest analyst ratings for IXI.

What is the current price target for IXICO?

0 Wall Street analysts have set twelve-month price targets for IXICO in the last year. has the lowest price target set, forecasting a price of £100,000 for IXICO in the next year.
View the latest price targets for IXI.

What is the current consensus analyst rating for IXICO?

IXICO currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IXI will outperform the market and that investors should add to their positions of IXICO.
View the latest ratings for IXI.

How do I contact IXICO's investor relations team?

IXICO's physical mailing address is 4th Fl, Griffin Court, 15 Long Lane, LONDON, EC1A 9PN, United Kingdom. The company's listed phone number is +44-20-37637499. The official website for IXICO is ixico.com.